Results 111 to 120 of about 2,705 (182)

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Opportunities for Typhoid Vaccination in India

, 2019
Typhoid fever, an infection with potentially life threatening complications, is responsible for 11 to 21 million illness episodes and 145,000 to 161,000 deaths each year globally.
Sindhu, Kulandaipalayam Natarajan, Kang, Gagandeep, Srinivasan, Manikandan, John, Jacob   +3 more
core   +1 more source

Safety and immunogenicity of conjugate vaccine for typhoid (Vi-DT): Finding from an observer-blind, active-controlled, randomized, non-inferiority, phase III clinical trial among healthy volunteers

Human Vaccines & Immunotherapeutics
Typhoid fever is a significant public health concern with most of the sufferers between 15 and 25 y of age in Nepal. We undertook this study to demonstrate Vi polysaccharide conjugated with diphtheria toxoid (Vi-DT) conjugate vaccine which is non ...
Dipesh Tamrakar, Pranodan Poudel, Pragya Thapa, Srijana Singh, Amit Khadgi, Sameera Thapa, Rajendra Tamrakar, Anmol Shrestha, Surendra Madhup, Ganesh Kumar Rai, Birendra Prasad Gupta, Tarun Saluja, Sushant Sahastrabuddhe, Rajeev Shrestha   +13 more
doaj   +1 more source

Comment on: development of Vi conjugate – a new generation of typhoid vaccine

Expert Review of Vaccines, 2014
Response to: Szu SC. Development of Vi conjugate – a new generation of typhoid vaccine. Expert Rev.
Subhash C, Arya, Nirmala, Agarwal
openaire   +2 more sources

ISEV2026 Abstract Book

Journal of Extracellular Vesicles, Volume 15, Issue S1, June 2026.
wiley   +1 more source

Seroefficacy of Vi Polysaccharide–Tetanus Toxoid Typhoid Conjugate Vaccine (Typbar TCV)

, 2018
Background Salmonella Typhi is the major cause of enteric fever in lower income countries. New conjugate vaccines show promise as public health interventions, however there are no efficacy data available from endemic areas.
Voysey, Merryn, Pollard, Andrew J., Andrew J Pollard, Merryn Voysey   +3 more
core   +1 more source

WHO preferred product characteristics for bivalent Salmonella Typhi/Paratyphi A vaccine for comprehensive protection against enteric fever– key considerations and research gaps [version 1; peer review: awaiting peer review]

Gates Open Research
In 2021, Salmonella Paratyphi A caused >2 million illnesses, resulting in >14,000 deaths, most of which occurred among children under 5 years of age in socioeconomically deprived populations.
Denise O. Garrett, John A. Crump, Jacob John, Melita A. Gordon, Matthew B. Laurens, Karen H. Keddy, Florian Marks, Xinxue Liu, Senjuti Saha, Andrew J. Pollard, Annelies Wilder-Smith, Ana Belen Ibarz Pavon, Alejandro Craviotto, John Clemens   +13 more
doaj   +1 more source

Comparison of Strategies and Incidence Thresholds for Vi Conjugate Vaccines Against Typhoid Fever: A Cost-effectiveness Modeling Study

, 2018
Background: Typhoid fever remains a major public health problem globally. While new Vi conjugate vaccines hold promise for averting disease, the optimal programmatic delivery remains unclear.
Stanaway, Jeffrey D., Luby, Stephen P., Lo, Nathan C., Bogoch, Isaac I., Garrett, Denise O., Gupta, Ribhav, Andrews, Jason R.   +6 more
core   +1 more source

Surgical Complications of Typhoid Fever: First National Typhoid Conference in Niamey, Niger [version 1; peer review: awaiting peer review]

Gates Open Research
Typhoid intestinal perforation (TIP) is a life-threatening, late complication of typhoid fever that disproportionately impacts children in low resource settings and continues to have devastating consequences worldwide.
Ide Kadi, Amadou Magagi Ibrahim, Abdou Soley Aboul Aziz, Zabeirou Oudou Abdou Aliou, Mahamadou Doutchi Altine, Boubacar Moctar, Adehossi Eric, Brah Souleymane, Mamadou Saidou, Joseph Emalieu Toko, Lassane Kabore, Assan Abdoul Nasser, Rachid Sani, Kathleen Neuzil, Harissou Adamou, Yakoubou Sanoussi, Abdoulaye Maman Bachir, Leah Sukri, Katherine Shafer, Saidou Adama, Laura Hobbs   +20 more
doaj   +1 more source

Logistics of implementing a large-scale typhoid vaccine trial in Kathmandu, Nepal

, 2019
Typhoid fever is estimated to affect over 20 million people per year worldwide, with infants, children, and adolescents in south-central and southeast Asia experiencing the greatest burden of disease.
Tonks, S, Shakya, M, Kelly, S, Basnyat, B, Pant, D, Karkey, A, Shrestha, S, Farooq, YG, Dongol, S, Mazur, O, Voysey, Merryn, Pollard, Andrew, Colin-Jones, R, Liu, Xinxue, Adhikari, A, Theiss-Nyland, Katherine, Smith, N   +16 more
core   +1 more source